ICD-10 Coding for Malignant Tumor of Breast(C50.0, C50.011, C50.011B)
Explore detailed ICD-10 coding guidelines for malignant neoplasm of the breast, including documentation requirements and common pitfalls.
Complete code families applicable to Malignant Tumor of Breast
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.011 | Malignant neoplasm of nipple and areola, right female breast | Use when the primary site of the breast cancer is the nipple and areola of the right breast. |
|
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast | Use when the primary site of the breast cancer is the upper-inner quadrant of the left breast. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMalignant Tumor of Breast
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Malignant Tumor of Breast.
Omitting receptor status in documentation
Impact
Clinical: Impacts treatment decisions and eligibility for targeted therapies., Regulatory: Non-compliance with documentation standards., Financial: May affect reimbursement for targeted therapies.
Mitigation
Include receptor status in all pathology reports, Verify documentation completeness before coding
Using unspecified codes when specific ones are available
Impact
Reimbursement: May lead to reduced reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the quality and specificity of health data.
Mitigation
Always document and code the specific site and laterality of the tumor.
Specificity of coding
Impact
Using unspecified codes when specific ones are available.
Mitigation
Educate providers on the importance of detailed documentation.